BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1693023)

  • 1. Interaction between theophylline and mexiletine.
    Ueno K; Miyai K; Seki T; Kawaguchi Y
    DICP; 1990 May; 24(5):471-2. PubMed ID: 1693023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of mexiletine on theophylline pharmacokinetics in patients with bronchial asthma].
    Inafuku M; Suzuki T; Ohtsu F; Hariya Y; Nagasawa K; Yoshioka Y; Nakahara Y; Hayakawa H
    J Cardiol; 1992; 22(1):227-33. PubMed ID: 1284909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of interaction between theophylline and mexiletine.
    Ueno K; Miyai K; Kato M; Kawaguchi Y; Suzuki T
    DICP; 1991; 25(7-8):727-30. PubMed ID: 1949927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral mexiletine-theophylline interaction.
    Katz A; Buskila D; Sukenik S
    Int J Cardiol; 1987 Nov; 17(2):227-8. PubMed ID: 3679607
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of disopyramide and mexiletine used alone and in combination for ventricular arrhythmias in patients with and without overt heart disease.
    Tanabe T; Takahashi K; Yoshioka K; Goto Y
    Int J Cardiol; 1991 Sep; 32(3):303-12. PubMed ID: 1724233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of mexiletine on the pharmacokinetics of theophylline in healthy volunteers.
    Stoysich AM; Mohiuddin SM; Destache CJ; Nipper HC; Hilleman DE
    J Clin Pharmacol; 1991 Apr; 31(4):354-7. PubMed ID: 2037708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mexiletine effects on theophylline disposition.
    Hurwitz A; Vacek JL; Botteron GW; Sztern MI; Hughes EM; Jayaraj A
    Clin Pharmacol Ther; 1991 Sep; 50(3):299-307. PubMed ID: 1914365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theophylline-mexiletine interaction: a case report.
    Kendall JD; Chrymko MM; Cooper BE
    Pharmacotherapy; 1992; 12(5):416-8. PubMed ID: 1437703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mexiletine, a new antiarrhythmic agent, for treatment of premature ventricular complexes.
    Mehta J; Conti CR
    Am J Cardiol; 1982 Feb; 49(2):455-60. PubMed ID: 6174042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proarrhythmia related to a kinetic and dynamic interaction of mexiletine and theophylline.
    Kessler KM; Interian A; Cox M; Topaz O; De Marchena EJ; Myerburg RJ
    Am Heart J; 1989 Apr; 117(4):964-6. PubMed ID: 2929410
    [No Abstract]   [Full Text] [Related]  

  • 11. Mexiletine: a new type I antiarrhythmic agent.
    Schrader BJ; Bauman JL
    Drug Intell Clin Pharm; 1986 Apr; 20(4):255-60. PubMed ID: 2421992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mexiletine-theophylline interaction.
    Stanley R; Comer T; Taylor JL; Saliba D
    Am J Med; 1989 Jun; 86(6 Pt 1):733-4. PubMed ID: 2729333
    [No Abstract]   [Full Text] [Related]  

  • 13. A double-blind crossover comparison of flecainide and slow-release mexiletine in the treatment of stable premature ventricular complexes.
    Capucci A; Di Pasquale G; Boriani G; Carini G; Balducelli M; Frabetti L; Carozzi A; Finzi A; Pinelli G; Magnani B
    Int J Clin Pharmacol Res; 1991; 11(1):23-33. PubMed ID: 1714885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of mexiletine and quinidine in the treatment of ventricular ectopia.
    Assey ME; Hudson WM; Hanger KH; Miller SC
    South Med J; 1985 May; 78(5):565-8. PubMed ID: 2581322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of delayed-action preparations of mexiletine and dihydroquinidine in the treatment of ventricular extrasystolic arrhythmia].
    Accettura D; De Toma L; Mangini SG; Lagioia R; Scrutinio D; Mastropasqua F; Caiati C; Rizzon P
    Cardiologia; 1987 Sep; 32(9):999-1003. PubMed ID: 2446764
    [No Abstract]   [Full Text] [Related]  

  • 16. The development of mexiletine in the management of ventricular dysrhythmias.
    Campbell NP; Chaturvedi NC; Shanks RG; Kelly JG; Strong JE; Adgey AA
    Postgrad Med J; 1977; 53 Suppl 1():114-9. PubMed ID: 69297
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment with mexiletine. Clinical and pharmacokinetic studies].
    Breithaupt H; Schmidt A
    Klin Wochenschr; 1988 Jun; 66(11):475-81. PubMed ID: 2457131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theophylline-isoniazid interaction.
    Torrent J; Izquierdo I; Cabezas R; Jané F
    DICP; 1989 Feb; 23(2):143-5. PubMed ID: 2728504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of mexiletine in the medium-term treatment of ventricular arrhythmias. A randomized, double-blind, crossover trial against placebo in ambulatory patients.
    Masotti G; Morettini A; Casolo GC; Ieri A; Zipoli A; Serneri GG
    J Int Med Res; 1984; 12(2):73-80. PubMed ID: 6202571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of theophylline metabolism by mexiletine in young male and female nonsmokers.
    Loi CM; Wei XX; Vestal RE
    Clin Pharmacol Ther; 1991 May; 49(5):571-80. PubMed ID: 2029830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.